Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Global peptide therapeutics market expected to generate revenue of around USD 43.26 billion by the end of 2024, growing at a CAGR of around 9.41% between 2018 and 2024. The peptide is a type of selective signaling molecule which binds to the cell-specific surface receptors or ion channels which helps to trigger the response for different functions of the cell for specific diseases.

Request Brochure Request Discount

18-Oct-2018 | Number of pages: 110 | Report Code: ZMR-3439 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the peptide therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the peptide therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the peptide therapeutics market on a global level.

In order to give the users of this report a comprehensive view of the peptide therapeutics market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Peptide Therapeutics Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type, and regional expansion of major participants involved in the market.

The study provides a decisive view on the peptide therapeutics market by segmenting it on the route of administration, type, type of manufacturers, type of molecule, technology, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further categorization into major countries including the U.S., the UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for peptide therapeutics market based on all segments in all the regions and countries.

The key players in the global peptide therapeutics market are Amgen Inc., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd., Lonza Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Sanofi, AstraZeneca PLC, and Novartis AG.

This report segments the global peptide therapeutics market as follows:

Global Peptide Therapeutics Market: Route of Administration Segment Analysis

  • Parenteral
  • Oral
  • Others

Global Peptide Therapeutics Market: Type Segment Analysis

  • Innovative
  • Generic

Global Peptide Therapeutics Market: Type of Manufacturers Segment Analysis

  • In-house
  • Outsourced

Global Peptide Therapeutics Market: Type of Molecule Segment Analysis

  • Vasopressin
  • Somatostatin
  • Calcitonin
  • Immunopeptide
  • Natriuretic
  • Others

Global Peptide Therapeutics Market: Technology Segment Analysis

  • Solid Phase
  • Liquid Phase
  • Hybrid Phase

Global Peptide Therapeutics Market: Application Segment Analysis

  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others

Global Peptide Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Diabetic Retinopathy Market – by Type (Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy) and by Management (Vitrectomy, Anti-VEGF Therapy, Laser Surgery, and Intraocular Steroid Injection): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017– 2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3504 | Report Format:

The report covers forecast and analysis for the diabetic retinopathymarketon a global and regional level. The study provides historical data from 2015along with a forecast from 2018to 2024based on revenue (USD Billion). The study includes drivers and restraints for the diabetic retinopathymarketal...Read More

Urgent Care Apps Market: by Type (In-hospital Collaboration & Communication Apps, Pre-hospital Triaging &Emergency Care Apps, and Post-hospital Apps) and by Clinical Area (Stroke, Trauma, Cardiac Conditions, and Others): Global Industry Perspective, Comprehensive Analysis,and Forecast, 2017 - 2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3498 | Report Format:

The report covers forecast and analysis for the urgent care appsmarketon a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018to 2024based on revenue (USD Million). The study includes drivers and restraints for the urgent care appsmarketa...Read More

Therapeutic Drug Monitoring Market: by Product (Equipment and Consumables), by Drug Class (Antiarrhythmic Drugs, Antiepileptic Drugs, Antibiotic Drugs,Immunosuppressant Drugs, Psychoactive Drugs, Bronchodilator Drugs, and Others), and by End-User(Commercial/Private Labs, Hospital Labs, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3497 | Report Format:

The report covers forecast and analysis for the therapeutic drug monitoringmarketon a global and regional level. The study provides historical data from 2015, 2016, 2017along with a forecast from 2018 to 2024based revenue (USD Billion). The study includes drivers and restraints for the therapeutic...Read More

Radiation Dose-Reduction System Market by Services Type (Solutions and Services), by Application (Computed Tomography, Fluoroscopy & Interventional Imaging, Nuclear Medicine, and Radiography & Mammography), and by End-User (Specialty Clinics, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis,and Forecast, 2018- 2024

Nov-2018 | Price : $ 4899.00 | Pages: 115 | Report Code: ZMR-3495 | Report Format:

The report covers the forecast and analysis for the radiation dose-reduction system market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD million). The study includes the drivers and restraints for ...Read More

Platelet Rich Plasma Market by Type (Pure Platelet-Rich Plasma, Leukocyte-Rich Platelet-Rich Plasma, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Platelet-Rich Fibrin), by Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), by Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others), and by End-User (Hospitals & Clinics and Research Institutions): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3484 | Report Format:

The report covers the forecast and analysis for the platelet rich plasma market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes the drivers and restraints for the platele...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.